Literature DB >> 16385628

Mechanism of pathogen-specific TLR4 activation in the mucosa: fimbriae, recognition receptors and adaptor protein selection.

Hans Fischer1, Masahiro Yamamoto, Shizuo Akira, Bruce Beutler, Catharina Svanborg.   

Abstract

The mucosal host defence discriminates pathogens from commensals, and prevents infection while allowing the normal flora to persist. Paradoxically, Toll-like receptors (TLR) control the mucosal defence against pathogens, even though the TLR recognise conserved molecules like LPS, which are shared between pathogens and commensals. This study proposes a mechanism of pathogen-specific mucosal TLR4 activation, involving adhesive ligands and their host cell receptors. TLR4 signalling was activated in CD14-negative, LPS-unresponsive epithelial cells by P fimbriated, uropathogenic Escherichia coli but not by a mutant lacking fimbriae. Epithelial TLR4 signalling in vivo involved the glycosphingolipid receptors for P fimbriae and the adaptor proteins Toll/IL-1R (TIR) domain-containing adaptor inducing IFN-beta (TRIF)/TRIF-related adaptor molecule (TRAM), but myeloid differentiation protein 88 (MyD88)/TIR domain-containing adaptor protein were not required for the epithelial response. Substituting the P fimbriae with type 1 fimbriae changed TLR4 signalling from the TRIF to the MyD88 adaptor pathway. In addition, the adaptor proteins and the fimbrial type were found to influence bacterial clearance. Trif(-/-) and Tram(-/-) mice remained infected with P fimbriated E. coli but cleared the type 1 fimbriated strain, while Myd88(-/-) mice became carriers of both the P and the type 1 fimbriated bacteria. Thus, TLR4 may be engaged specifically by pathogens, when the proper cell surface receptors are engaged by virulence ligands.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16385628     DOI: 10.1002/eji.200535149

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  49 in total

Review 1.  Host-pathogen checkpoints and population bottlenecks in persistent and intracellular uropathogenic Escherichia coli bladder infection.

Authors:  Thomas J Hannan; Makrina Totsika; Kylie J Mansfield; Kate H Moore; Mark A Schembri; Scott J Hultgren
Journal:  FEMS Microbiol Rev       Date:  2012-05       Impact factor: 16.408

2.  TRIF mobilizes unique primary defense against Gram-negative bacteria in intestinal interface.

Authors:  John Sotolongo; Saravana Kanagavelu; Jinhee Hyun; Jose Ruiz; Masayuki Fukata
Journal:  Gut Microbes       Date:  2012-06-20

Review 3.  Unifying themes in microbial associations with animal and plant hosts described using the gene ontology.

Authors:  Trudy Torto-Alalibo; Candace W Collmer; Michelle Gwinn-Giglio; Magdalen Lindeberg; Shaowu Meng; Marcus C Chibucos; Tsai-Tien Tseng; Jane Lomax; Bryan Biehl; Amelia Ireland; David Bird; Ralph A Dean; Jeremy D Glasner; Nicole Perna; Joao C Setubal; Alan Collmer; Brett M Tyler
Journal:  Microbiol Mol Biol Rev       Date:  2010-12       Impact factor: 11.056

Review 4.  Host-pathogen interactions in urinary tract infection.

Authors:  Greta R Nielubowicz; Harry L T Mobley
Journal:  Nat Rev Urol       Date:  2010-07-20       Impact factor: 14.432

5.  Pellino-3 promotes endotoxin tolerance and acts as a negative regulator of TLR2 and TLR4 signaling.

Authors:  Michael B Murphy; Yanbao Xiong; Goutham Pattabiraman; Tissa T Manavalan; Fu Qiu; Andrei E Medvedev
Journal:  J Leukoc Biol       Date:  2015-08-26       Impact factor: 4.962

Review 6.  The role of Toll-like receptors in renal diseases.

Authors:  Anna Gluba; Maciej Banach; Simon Hannam; Dimitri P Mikhailidis; Agata Sakowicz; Jacek Rysz
Journal:  Nat Rev Nephrol       Date:  2010-02-23       Impact factor: 28.314

Review 7.  Therapeutic approaches targeting intestinal microflora in inflammatory bowel disease.

Authors:  Akira Andoh; Yoshihide Fujiyama
Journal:  World J Gastroenterol       Date:  2006-07-28       Impact factor: 5.742

8.  Impaired cytokine expression, neutrophil infiltration and bacterial clearance in response to urinary tract infection in diabetic mice.

Authors:  Ahmet Ozer; Cengiz Z Altuntas; Fuat Bicer; Kenan Izgi; Scott J Hultgren; Guiming Liu; Firouz Daneshgari
Journal:  Pathog Dis       Date:  2015-02-05       Impact factor: 3.166

Review 9.  Genetics of innate immunity and UTI susceptibility.

Authors:  Bryndís Ragnarsdóttir; Nataliya Lutay; Jenny Grönberg-Hernandez; Bela Köves; Catharina Svanborg
Journal:  Nat Rev Urol       Date:  2011-07-12       Impact factor: 14.432

Review 10.  TLR-mediated immune responses in the urinary tract.

Authors:  Jeongmin Song; Soman N Abraham
Journal:  Curr Opin Microbiol       Date:  2008-02-01       Impact factor: 7.934

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.